 Oarsman Capital Inc. purchased a new stake in  Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 726 shares of the technology company’s stock, valued at approximately $209,000.
Oarsman Capital Inc. purchased a new stake in  Veeva Systems Inc. (NYSE:VEEV – Free Report) in the 2nd quarter, HoldingsChannel.com reports. The fund purchased 726 shares of the technology company’s stock, valued at approximately $209,000. 
Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Veeva Systems by 2.2% in the 1st quarter. Vanguard Group Inc. now owns 14,760,566 shares of the technology company’s stock valued at $3,418,990,000 after purchasing an additional 315,421 shares during the last quarter. Alliancebernstein L.P. increased its stake in Veeva Systems by 10.7% in the 1st quarter. Alliancebernstein L.P. now owns 5,499,651 shares of the technology company’s stock valued at $1,273,884,000 after buying an additional 532,269 shares during the period. T. Rowe Price Investment Management Inc. increased its stake in Veeva Systems by 0.7% in the 1st quarter. T. Rowe Price Investment Management Inc. now owns 5,203,867 shares of the technology company’s stock valued at $1,205,372,000 after buying an additional 34,169 shares during the period. Price T Rowe Associates Inc. MD increased its stake in Veeva Systems by 20.9% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,992,372 shares of the technology company’s stock valued at $924,754,000 after buying an additional 689,700 shares during the period. Finally, JPMorgan Chase & Co. increased its stake in Veeva Systems by 7.5% in the 1st quarter. JPMorgan Chase & Co. now owns 3,230,758 shares of the technology company’s stock valued at $748,341,000 after buying an additional 225,125 shares during the period. Hedge funds and other institutional investors own 88.20% of the company’s stock.
Wall Street Analysts Forecast Growth
Several equities analysts have issued reports on VEEV shares. Mizuho boosted their price objective on shares of Veeva Systems from $295.00 to $325.00 and gave the company an “outperform” rating in a research note on Friday, August 29th. Citigroup upped their price target on shares of Veeva Systems from $329.00 to $349.00 and gave the stock a “buy” rating in a research note on Thursday, August 28th. William Blair reaffirmed an “outperform” rating on shares of Veeva Systems in a research note on Friday, October 17th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Veeva Systems in a research note on Wednesday, October 8th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $325.00 price target on shares of Veeva Systems in a research note on Thursday, August 28th. Seventeen analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $307.58.
Insider Activity at Veeva Systems
In related news, insider Thomas D. Schwenger sold 3,350 shares of the stock in a transaction dated Thursday, October 2nd. The shares were sold at an average price of $300.04, for a total value of $1,005,134.00. Following the sale, the insider directly owned 23,773 shares of the company’s stock, valued at approximately $7,132,850.92. This represents a 12.35% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of the stock in a transaction dated Tuesday, October 7th. The shares were sold at an average price of $306.62, for a total transaction of $1,839,720.00. Following the completion of the sale, the insider directly owned 25,325 shares in the company, valued at approximately $7,765,151.50. The trade was a 19.15% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders have sold 24,665 shares of company stock valued at $7,438,000. Insiders own 10.30% of the company’s stock.
Veeva Systems Trading Down 1.8%
Shares of NYSE VEEV opened at $286.22 on Thursday. The stock has a market cap of $46.91 billion, a price-to-earnings ratio of 58.77, a PEG ratio of 2.25 and a beta of 0.98. Veeva Systems Inc. has a 52 week low of $201.54 and a 52 week high of $310.50. The company’s 50-day moving average price is $285.16 and its 200 day moving average price is $271.63.
Veeva Systems (NYSE:VEEV – Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The technology company reported $1.26 EPS for the quarter, missing analysts’ consensus estimates of $1.90 by ($0.64). The business had revenue of $789.08 million during the quarter, compared to analyst estimates of $768.49 million. Veeva Systems had a net margin of 27.29% and a return on equity of 13.72%. Veeva Systems’s revenue was up 16.7% on a year-over-year basis. During the same period in the previous year, the company posted $1.62 earnings per share. Veeva Systems has set its Q3 2026 guidance at 1.940-1.950 EPS. FY 2026 guidance at 7.780-7.780 EPS. As a group, research analysts expect that Veeva Systems Inc. will post 4.35 earnings per share for the current year.
About Veeva Systems
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Stories
- Five stocks we like better than Veeva Systems
- Quiet Period Expirations Explained
- These 3 High-Momentum ETFs Are Riding the Tech Wave
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Verizon Results Trigger Rebound in High-Yield Stock
- 3 REITs to Buy and Hold for the Long Term
- Picks & Shovels: Investing in the Physical Foundation of AI
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						 
						